Together, the TRIUMPH, TRANSCEND, and SYNERGY programs represent one of the most comprehensive Phase 3 development programs in obesity pharmacotherapy
Understanding the current peptide regulatory landscape helps contextualize these timelines, as regulatory agencies worldwide are moving at different speeds on GLP-1 approvals
About Welcome back By clicking Continue to join or sign in, you agree to LinkedIns User Agreement, Privacy Policy, and Cookie Policy
Check out our video on how to do injections safely - scroll to the bottom of the page
We surface the things that matter on GLP-1s specifically: protein (to help avoid muscle loss), fiber (manage the GI side effects), sodium, and total calories
Medical weight loss isn't covered by most Georgia insurance plans, so cash-pay candidacy and clinical fit matter more than zip-code-level prevalence